1/10/2023 -Prayer Request for Young Mother & her twin babies:
We ask your urgent prayers for one of our Gabriel Project moms and her little ones.
Martha just gave birth to twins; the babies were not due until March 15, so are very small and are in the NICU. Martha developed a severe infection last night and is also hospitalized. Please offer your prayers for the quick healing of this new family!
1/10/2023 - USCCB Action Alert: House votes this week to protect babies born alive after abortion. Urge your member to vote YES.
Please review the Action Alert below from USCCB concerning a bill being considered in the U.S. House of Representatives this week. Please consider contacting your representative and please share with your contacts!
This Wednesday, the House of Representatives is scheduled to vote on the Born-Alive Abortion Survivors Protection Act. Please act now to tell your representative to vote “Yes” on this bill. It is a horrific reality in this country that children who are fully born and living after a failed abortion can in many instances be left to die without medical attention and basic needs met. The Born-Alive Survivors Protection Act would require health care professionals to offer the same level of medical care to such children as would be appropriate for a premature baby born at the same age. Please make your voice heard and ask Congress to help save these vulnerable survivors among us.
1/9/2023 -Your help is urgently needed! - January pro-life events: (See flyers below)
We’re writing to send a reminder about the upcoming pro-life events this month – Eucharistic Adoration on the 19th-20th (next week) & Texas Rally for Life on the 28th.
We need your help in publicizing these events. We need more adorers for our overnight Holy Hour – particularly during the overnight hours and for the final hour (7am-8am). Please consider registering a group from your parish respect life group, especially if your parish is close to the seminary. Register at https://archgh.cventevents.com/HolyHourforLife.
We very much need your help in publicizing the Texas Rally for Life. At this time, we have only a very few signed up to attend. If we cannot increase registration by this week, we will most likely have to cancel the Archdiocesan bus as we will lose a significant amount of money if we can’t find more people to attend.
(If your parish is taking a bus, please let me know how registration is going so we can direct individuals to your bus if we have to cancel the Archdiocesan transportation).
1/6/2023 - U.S. Bishops’ Pro-Life Chairman Denounces FDA Action on Chemical Abortion Pill:
Please see the message below from the USCCB’s Pro-Life Chairman on the FDA’s recent expansion of abortion pill access in the U.S.
WASHINGTON – On Tuesday, the U.S. Food and Drug Administration (FDA) announced the loosening of safety requirements to allow retail pharmacies, through a simple certification process, to distribute the chemical abortion drug, mifepristone (previously commonly known as RU-486), by prescription. Bishop Michael F. Burbidge of Arlington, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities, issued the following statement in response:
“The Catholic Church is consistent in its teaching on upholding the dignity of all life, and that must include care for both women and their children. We decry the continuing push for the destruction of innocent human lives and the loosening of vital safety standards for vulnerable women. This week’s action by the FDA not only advances the obvious tragedy of taking the lives of the preborn but is also harmful to women in need.
“The rate of serious complications after chemical abortion is considerably higher than after surgical abortion. Overturning the safety protocols around abortion-causing drugs to effectively make them available on demand at pharmacies, requiring no in-person medical supervision, facilitates the isolation of critically vulnerable pregnant women, and invites more risk, pain, and trauma. It may also result in new violations of conscience for pharmacy workers who cannot dispense such drugs. The FDA should protect the life and health of both mothers and children, not loosen safety standards under industry or political pressures. We call on the Administration to correct its policy priorities and stand with mothers in need. They deserve better.”
###
Thank you, Julie Fritsch Dumalet